All News about Ligand Pharm
![](https://cdn.benzinga.com/files/images/story/2023/07/17/novn.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230717515826/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://ml.globenewswire.com/media/1b89f54a-2c5d-458d-abc4-321d45b03a21/small/2019-logo-150x35-jpg-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Recap: Ligand Pharmaceuticals Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Ligand Pharmaceuticals Earnings Preview
February 21, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/05/16/vkng.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230516005532/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20230504006023/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20230424005882/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://mms.businesswire.com/media/20230222005940/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/02/21/tvtx_mark_composite_dark__d30eb06cf1752b438bfffb1b5d6b0b38.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230217005377/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_118.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230206005621/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand to Report Fourth Quarter Financial Results on February 22
February 06, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/01/31/biotech_shutter.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230106005095/en/346436/5/Ligand-Logo-Registered5.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image-tesla4_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/16/oabi_logo_light__61faa132e07c86aa87fdedf3269e527f.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/13/logo_light__b69d6d372d65240abf487ba5457c0962.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221213005675/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Provides Highlights from its Investor and Analyst Day Event
December 13, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221205005272/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Pharmaceuticals Names Director Todd C. Davis as CEO
December 05, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221116005413/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand to Hold Investor and Analyst Day on December 13
November 16, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221107006075/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Reports Third Quarter 2022 Financial Results
November 07, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5954.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20521.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/biotech6.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221101006208/en/346436/5/Ligand-Logo-Registered5.jpg)
Ligand Announces Completion of OmniAb Spin-Off
November 01, 2022
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.